Literature DB >> 21910983

On the quantitation of an agonist with dual but opposing components of action: application to vascular endothelial relaxation.

Neil S Lamarre1, Tom Parry, Ronald J Tallarida.   

Abstract

In this communication we show that the same principle that underlies the use of the isobolograph for assessing agonist interactions also leads to a method for analyzing the opposing effects of a single agonist. This is the principle of dose equivalence whose application is illustrated here and applied to the endothelium-dependent relaxing component of two putative vasoconstrictor peptides. These studies, employing angiotensin II and endothelin-1, were conducted with isolated preparations of rat aorta that were measured for agonist-induced isometric tension development in both endothelial-denuded and -intact vessels. The dose-effect relation of the relaxing component of each agonist, which should not be calculated from simple effect subtraction, was derived by the method described here.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21910983      PMCID: PMC4010114          DOI: 10.1016/j.ejphar.2011.08.007

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

Review 1.  Drug synergism: its detection and applications.

Authors:  R J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2001-09       Impact factor: 4.030

2.  The problem of synergism and antagonism of combined drugs.

Authors:  S LOEWE
Journal:  Arzneimittelforschung       Date:  1953-06

3.  Isobolographic analysis for combinations of a full and partial agonist: curved isoboles.

Authors:  Yury Grabovsky; Ronald J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2004-06-02       Impact factor: 4.030

4.  A further comment on testing for drug synergism.

Authors:  Ronald J Tallarida
Journal:  Pain       Date:  1992-12       Impact factor: 6.961

Review 5.  The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations.

Authors:  Ronald J Tallarida; Robert B Raffa
Journal:  Pharmacol Ther       Date:  2010-05-28       Impact factor: 12.310

Review 6.  The endothelium in health and disease.

Authors:  P M Vanhoutte; T Scott-Burden
Journal:  Tex Heart Inst J       Date:  1994

7.  Testing for synergism over a range of fixed ratio drug combinations: replacing the isobologram.

Authors:  R J Tallarida; R B Raffa
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

8.  Comparison of nitric oxide and prostacyclin in endothelium-dependent vasorelaxation of human umbilical artery at midgestation.

Authors:  H Izumi; Y Makino; H Mohtai; K Shirakawa; R E Garfield
Journal:  Am J Obstet Gynecol       Date:  1996-08       Impact factor: 8.661

9.  Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations.

Authors:  A P Goldman; R E Delius; J E Deanfield; D J Macrae
Journal:  Ann Thorac Surg       Date:  1995-08       Impact factor: 4.330

10.  Endothelium-dependent relaxation of rabbit middle cerebral artery to a histamine H3-agonist is reduced by inhibitors of nitric oxide and prostacyclin synthesis.

Authors:  L Ea Kim; J Javellaud; N Oudart
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

View more
  2 in total

Review 1.  Revisiting the isobole and related quantitative methods for assessing drug synergism.

Authors:  Ronald J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2012-04-17       Impact factor: 4.030

2.  Cocaine synergism with α agonists in rat aorta: computational analysis reveals an action beyond reuptake inhibition.

Authors:  Neil S Lamarre; Robert B Raffa; Ronald J Tallarida
Journal:  Drug Alcohol Depend       Date:  2012-12-25       Impact factor: 4.492

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.